About adalimuma b
TNF inhibitor biologic
Used for
- Rheumatoid arthritis and juvenile idiopathic arthritis
- Psoriatic arthritis and ankylosing spondylitis
- Plaque psoriasis and hidradenitis suppurativa
- Crohn’s disease and ulcerative colitis
Usual adult dose
Usually 40 mg injected under the skin every other week; schedules vary by condition.
Usual dose in children
For certain conditions, typically weight-based injections every other week; dose and eligibility vary by age and condition.
Common side effects
- Injection-site reactions
- Respiratory or other infections
- Headache
- Rash
Important warnings
- Can cause serious infections, including tuberculosis; screening is needed.
- Avoid live vaccines during treatment.
- Rarely, may cause cancers, nerve disorders, or heart failure to worsen.
- Do not use with other TNF blockers or anakinra.
Pregnancy
May be used when clinically needed; discuss treatment timing with a healthcare professional. Infant live vaccines may require planning after exposure.
Breastfeeding
Small amounts may enter milk; available evidence suggests low risk, but discuss with a healthcare professional.
Interactions
- Live vaccines
- Other TNF blockers, such as infliximab or etanercept
- Anakinra or abatacept
- Some immunosuppressants, including azathioprine
AI-generated from general medical knowledge, not from this product's official leaflet. It may be incomplete or out of date. Not medical advice — ask a pharmacist or doctor before making any decision.